Moderna And Abbot CEOs On The COVID-19 Vaccine And Testing Arms Race

The transcript covers the availability and trials of COVID-19 vaccines, focusing on Moderna's progress and challenges in manufacturing and distribution. It discusses the accuracy and challenges of rapid testing, particularly Abbott's tests, and addresses political and safety concerns in vaccine development. The role of platform technologies and data management in testing is also explored.

How do rapid tests differ from traditional PCR tests in terms of accuracy?

What measures are being taken to ensure the safety and efficacy of vaccines during the pandemic?

Why has Moderna chosen not to make a profit off their vaccines during the pandemic?

What role does gene sequencing play in the development of vaccines?